CTNNB1 and hepatocellular carcinoma: This heterogeneity is also seen in patients; even among HCC with similar, highly active CTNNB1 mutations affecting the D32-S37 region of exon 3, β-catenin still displays heterogeneous expression/localization patterns ranging from absent to rare to frequent nuclear staining (Rebouissou et al., 2016).